Company Filing History:
Years Active: 1999
Title: Jo-Ann Breitman: Innovator in Receptor Tyrosine Kinase Research
Introduction
Jo-Ann Breitman is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of biomedical research, particularly in the study of receptor tyrosine kinases. Her work has implications for understanding various cellular processes and potential therapeutic applications.
Latest Patents
Jo-Ann Breitman holds a patent for a novel receptor tyrosine kinase protein and its isoforms. This patent, which is classified under 1 patent, discloses DNA segments encoding the novel protein and isoforms expressed in cells of the endothelial lineage. Additionally, the patent outlines methods for identifying ligands capable of binding to the receptor protein, as well as methods for screening agonist or antagonist substances that interact with the protein and a ligand.
Career Highlights
Jo-Ann Breitman is affiliated with Mount Sinai Hospital Corporation, where she conducts her research. Her work has been instrumental in advancing the understanding of receptor tyrosine kinases and their role in cellular signaling pathways.
Collaborations
Throughout her career, Jo-Ann has collaborated with notable colleagues, including Martin L Breitman and Janet Rossant. These collaborations have enriched her research and contributed to the advancement of knowledge in her field.
Conclusion
Jo-Ann Breitman is a distinguished inventor whose work on receptor tyrosine kinases has the potential to impact biomedical research significantly. Her contributions continue to pave the way for future innovations in the field.